Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pagoclone in Persistent Developmental Stuttering
NCT00216255Phase 2Completed
- Sponsor
- Endo International plc
- Start
- Apr 2005
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pagoclone in developmental stuttering, sponsored by Endo International plc. Started Apr 2005; status: completed.
02
Drugs
pagoclone
03
Conditions
developmental stuttering
Beyond the preview
Go deeper on NCT00216255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00216255.